Cellmid Share Price and Company Fundamentals
Last traded: Today at 12:06 AM
Cellmid Limited, a life sciences company, researches, develops, and commercializes diagnostic and therapeutic products for cancer and various chronic inflammatory conditions in Australia, the United States, and Japan. The company offers midkine, a driver and modulator of inflammatory diseases, including chronic inflammatory diseases and cancer; and focuses on blocking midkine, a protein for autoimmune disorders, chronic inflammation, osteoporosis, cardiovascular diseases, cancer, and neurodegenerative diseases. It also develops and sells over-the-counter products; and a range of FGF5 inhibitor hair growth products under the evolis, evolis Professional, Lexilis Hybrid, Jo-Ju RED, and Lexilis BLACK brands. In addition, the company sells SARS-CoV-2 antibody kits and PCR tests. It markets its products through retailers and wholesalers, as well as through a direct-to-consumer e-commerce platform. Cellmid Limited was incorporated in 2004 and is based in Sydney, Australia.
|Primary activities||Developer of products to treat various cancers and chronic inflammatory diseases|
|Industry / Sector||Biotechnology / Healthcare|
|Mailing address||55 Clarence Street Suite 204 Level 2 Sydney NSW 2000 Australia|
|Phone / Fax||61 2 9221 6830 / 61 2 9221 8535|
|Share registry||AUTOMIC REGISTRY SERVICES|
Cellmid does not pay dividends.
As of Jul 2021, following are the company executives and directors listed on Cellmid.
|Ms. Maria Halasz||CEO, MD & Exec. Director||549.82k|
|Mr. Koichiro Koike||Managing Director of Advangen Inc||63||303.67k|
|Mr. Matthew Dudek||Group Financial Controller|
|Mr. Dominic Burg||Chief Operating Officer|
|Dr. Graham Robertson||Head of R&D|
|Ms. Trish Frelan||Global Head of Marketing Advangen Pty Ltd|
|Mr. Lee Tamplin B.A.||Company Sec.|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Cellmid is 10.31M and its enterprise value is 4.04M. The enterprise value to revenue ratio of CDY is 0.61.
Companies similar to Cellmid (CDY)
Cellmid (ASX:CDY) Frequently Asked Questions
1. What is Cellmid's Stock Symbol?
Cellmid trades on ASX under the ticker symbol "CDY".
2. What is Cellmid's stock price today?
One share of CDY stock can currently be purchased for approximately $0.055.
3. How can I contact Cellmid?
Cellmid's mailing address is 55 Clarence Street Suite 204 Level 2 Sydney NSW 2000 Australia. The company can be reached via phone at 61 2 9221 6830.
4. What is Cellmid's official website?
The official website of Cellmid is http://www.cellmid.com.au.
5. Which share registry manages Cellmid's stock?
Cellmid's stock is managed by AUTOMIC REGISTRY SERVICES.